• HOME
  • 森下竜一 寄附講座教授
  • 概要・沿革
  • グループ紹介
  • 核酸医薬グループ
  • 認知症グループ
  • 心・血管グループ
  • 健康発達医学グループ
  • 免疫・脳血管・神経グループ
  • 共同研究グループ
  • 院生、研究生、修士大募集
  • 技術補佐員等募集
  • CGT写真館
  • MORISHITA AWARD
  • 臨床試験
  • 外来診察担当表
  • お知らせ
  • 関連リンク
  • お問合せ
Home ＞ グループ紹介 ＞ 心・血管グループ

グループ紹介

心・血管グループ
  Gリーダー 研究テーマ 所属メンバー 主な論文

主な論文

News 臨床研究 英字論文 英字著書 和文著書 日本語総説・解説 国際学会 国内学会

国際学会

  • ＜2021年＞
  • Joint Meeting of the European Society of Hypertension (ESH) and the International Society ofHypertension (ISH) 2021 (4.11-14. Glasgow, UK)
    Inhibition of Periostin Protected from Development of Ihfalammation in Rhabdmyolysis-induced Acute Kidney Injury.
    Jun Muratsu, Yoshiaki Taniyama, Fumihiro Sanada, Nobutaka Koibuchi, Naruto Katsuragi, Kana Shibata, Tatsuya Fujikawa, Ryoko Nakagawa, Atsuyuki Morishima, Katsuhiko Sakaguchi , Hiromi Rakugi and Ryuichi Morishita
  • ＜2020年＞
  • ERA-EDTA 2020: The 57th Europian Renal Association-European Dialysis and Transplant Association Congress. (6.6-9. Milano, Itary)
    Hepatocyte growth factor (HGF) preclude high-fat diet-induced obesity and improved insulin resistance in mice.
    Jun Muratsu, Fumihiro Sanada, Yoshiaki Taniyama, Masaaki Iwabayashi, Kana Shibata, Nobutaka Koibuchi, Naruto Katsuragi, Ryoko Nakagawa, Atsuyuki Morishima, Katsuhiko Sakaguchi, Hiromi Rakugi, Ryuichi Morishita
  • ＜2019年＞
  • ERA-EDTA 2019: The 56th European Renal Association-European Dialysis and Transplant Association Congress. (6.16. Budapest, Hungary)
    Blockade of Periostin Protected from development of inflammation in rhabdomyolysis-induced acute kidney injury.
    Jun Muratsu, Yoshiaki Taniyama, Fumihiro Sanada, Kana Shibata, Rei Ohtsu, Atsuyuki Morishima, Katsuhiko Sakaguchi, Hiromi Rakugi, Ryuichi Morishita
    Nephrology Dialysis Transplantation, Volume 34, Issue Supplement_1, June 2019, gfz106.FP256
  • ＜2018年＞
  • International Society of Hypertension (ISH) 2018 Scientific Meeting (9.21. Beijing, China)
    LCZ696, an Angiotensin Receptor with Neprilysin Inhibitor, Attenuates Renal Fibrosis and Glomerular Injury in a Mouse Model of Salt-sensitive Hypertension Using Angiotensin 1 Receptor Knockout Mouse.
    Rei Otsu, Yoshiaki Taniyama, Fumihiro Sanada, Jun Muratsu, Tatsuya Fujikawa, Kana Shibata, Kanako May Brule, Hiromi Rakugi, Ryuichi Morishita
  • International Society of Hypertension (ISH) 2018 Scientific Meeting (9.23. Beijing, China)
    Periostin splicing variant regulates cardiac fibrosis after myocardial infarction.
    Fumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, Tatsuya Fujikawa, Kana Shibata, Kanako May Brule, Hiromi Rakugi, Ryuichi Morishita
  • ERA-EDTA 2018: The 55th European Renal Association-European Dialysis and Transplant Association Congress (5.26. Copenhagn, Denmark)
    Selective blockade of periostin exon 17 protected from development of renal fibrosis.
    Jun Muratsu, Yoshiaki Taniyama, Fumihiro Sanada, Kana Shibata, Rei Ohtsu, Atsuyuki Morishima, Katsuhiko Sakaguchi, Hiromi Rakugi, Ryuichi Morishita
    Nephrology Dialysis Transplantation, Volume 33, Issue suppl_1, May 2018, Page i471
  • ＜2017年＞
  • 15th Japan-Korea Joint Symposium of Vascular Biology (8.23. Muju, Korea)
    LCZ696, an Angiotensin Receptor with Neprilysin Inhibitor, Attenuates Renal Fibrosis and Glomerular Injury in a Mouse Model of Salt-sensitive Hypertension Using Angiotensin 1 Receptor Knockout Mouse
    Otsu R, Taniyama Y, Sanada F, Muratsu J, Shibata K, Brule M K, Rakugi H, Morishita R
  • ＜2016年＞
  • American Herat Association Scientific Session 2016 (11.16, New Orleans)
    Selective blockade of periostin exon-17 improves heart failure after myocardial infarction
    Sanada F, Taniyama Y, Otsu R, Muratsu J, Rakugi H, and Morishita R
  • 19th International Vascular Biology Meeting (11.1, Boston)
    Selective blockade of periostin exon-17 ameliorates heart failure after myocardial infarction
    Sanada F, Taniyama Y, Muratsu J, Otsu R, Rakugi H, and Morishita R
  • 19th International Vascular Biology Meeting (11.1, Boston)
    LCZ696, an Angiotensin Receptor Neprilysin Inhibitor, Attenuates Renal Fibrosis and Glomerular Injury in a Mouse Model of Salt-sensitive Hypertension Using Angiotensin 1 Receptor Knockout Mouse
    Otsu R, Taniyama Y, Sanada F, Muratsu J, Ikeda-Iwabu Y, Shibata K, Brule M K, Rakugi H, and Morishita R
  • The 26th Scientific Meeting of the International Society of Hypertension (9.26, Seoul)
    Selective blockade of periostin exon-17 improves cardiac performance in rat myocardial ischemia model
    Sanada F, Taniyama Y, Muratsu J, Otsu R, Rakugi H, Morishita R
  • The 26th Scientific Meeting of the International Society of Hypertension (9.27, Seoul)
    Induction of Angiogenesis by A Type III Phosphodiesterase Inhibitor Through Activation of PPAR Gamma and cAMP Pathways
    Sanada F, Taniyama Y, Muratsu J, Otsu R, Rakugi H, Morishita R
  • ＜2015年＞
  • American Heart Association Scientific Session 2015 (11.8, Orlando)
    e-Abstract Session; Thrombosis, Immunity and Inflammation
    Coagulation Factor Xa Promotes Endothelial Cell Senescence Via P53 Up-regulation
    Sanada F, Taniyama Y, Muratsu J, Otsu R, Carracedo M, Ikeda-Iwabu Y, Rakugi H, Morishita R
  • American Heart Association Scientific Session 2015 (11.9, Orlando)
    Microcirculation and Cerebral/Coronary/Peripheral Circulation II
    PDE3 Inhibitor, Cilostazol, Ameliorates Ischemic Hindlimb Through cAMP and PPARγ Activation
    Sanada F, Kanbara Y, Taniyama Y, Otsu R, Iwabwabayashi M, Carracedo M, Muratsu J, Ikeda-Iwabu Y, Yamamoto K, Sugimoto K, Rakugi H, Morishita R
  • The 21st International Congress of Personalized Medicine (10.17, Osaka)
    Vicious cycle of inflammation via humoral factor in macrophages and adipocytes is inhibited by HGF
    Otsu R, Taniyama Y, Kusunoki H, Sanada F, Muratus J, Ikeda-Iwabu Y, Rakugi H, Morishita R
  • The 21st Annual Meeting of Japan Socity of Gene Therapy, The 1st International Symposium of the Asia-Pasific Gene Therapy Consortium (7.25, Osaka)
    Selective Blockade of Periostin Exon-17 Ameriorates Cardiac Performance in Acute Myocardial Infarction (Young Investigator Award Session)
    Fumihiro Sanada, Yoshiaki Taniyama, Jun Muratsu, Yuka Ikeda-Iwabu, Rei Otsu, Kana Shibata, May Kanako Brule, Hiromi Rakugi, Ryuichi Morishita
  • The 21st Annual Meeting of Japan Socity of Gene Therapy, The 1st International Symposium of the Asia-Pasific Gene Therapy Consortium (7.25, Osaka)
    Abgiotensin II type I receptor antagonist improves lipoprotein (a) induced atherosclerosisi via integrin aVb3 pathway (Oral Session V)
    Jun Muratsu, Yoshiaki Taniyama, Masaaki Iwabayashi, Fumihiro Sanada, Yuka Ikeda-Iwabu, Rei Otsu, Kana Shibata, May Kanako Brule, Hiromi Rakugi, Ryuichi Morishita
  • The 21st Annual Meeting of Japan Socity of Gene Therapy, The 1st International Symposium of the Asia-Pasific Gene Therapy Consortium (7.25, Osaka)
    Vicious cycle ofinflammation via humoral factor in macrophages and adipocytes is inhibited by HGF (Poster Session II)
    Rei Otsu, Yoshiaki Taniyama, Hiroshi Kusunoki, Fumihiro Sanada, Jun Muratsu, Hiromi Rakugi, Ryuichi Morishita
  • The 21st Annual Meeting of Japan Socity of Gene Therapy, The 1st International Symposium of the Asia-Pasific Gene Therapy Consortium (7.25, Osaka)
    Periostin C-terminus is involved in tumor-stromal interactions in triple negative breast cancer (Poster Session II)
    Yuka Ikeda-Iwabu, Yoshiaki Taniyama, Fumihiro Sanada, Jun Muratsu, Emi Aomatsu, Kana Shibata, May Kanako Brule Hiromi Rakugi, Ryuichi Morishita
  • The 21st Annual Meeting of Japan Socity of Gene Therapy, The 1st International Symposium of the Asia-Pasific Gene Therapy Consortium (7.25, Osaka)
    Oral Session 2 Basic Research
    Chair parson; Yoshiaki Taniyama
  • The 21st Annual Meeting of Japan Socity of Gene Therapy, The 1st International Symposium of the Asia-Pasific Gene Therapy Consortium (7.24, Osaka)
    Symposium
    Challenge to Incurable Disease
    Chair parson; Yoshiaki Taniyama
  • ＜2014年＞
  • The 31st Annual Meeting of the International Society for Heart Research Japanese Section (11.28, Nagoya)
    Hepatocyte growth factor attenuates LPS-induced vascular damage and inflammation via EGFR ubiquitination (Young Investigetor Travel Grant Award)
    K Shimizu, Y Taniyama, F Sanada, H Rakugi, R Morishita
  • The 31st Annual Meeting of the International Society for Heart Research Japanese Section (11.28, Nagoya)
    Cilostazol enhances blood flow in ischemic limb through PPARγ/hepatocyte growth factor/eNOS pathway (Young Investigetor Travel Grant Award)
    Y Kanbara, F Sanada, Y Taiyama, M Carracedo, R Otsu, K Shimizu, H Rakugi, R Morishita
  • The 31st Annual Meeting of the International Society for Heart Research Japanese Section (11.28, Nagoya)
    Vicious cycle of inflammation via a humoral factor in macrophages and adipocytes is inhibited by HGF (Young Investigetor Travel Grant Award)
    R Otsu, Y Taniyama, H Kusunoki, H Rakugi, R Morishita
  • Joint Meeting ESH-ISH HYPERTYENSION ATHENS 2014 (6.14, Athens, Greece)
    Stem Cell Factor Activates Hypoxic Carduac Stem Cells reversing Myocardial Aging (Oral)
    Sanada F, Taniyama Y, Azuma J, Kanbara Y, Ikeda-Iwabu Y, Rakugi H, Morishita R
  • Joint Meeting ESH-ISH HYPERTYENSION ATHENS 2014 (6.15, Athens, Greece)
    Cilostazol inproves Blood Flow in Hind Limb Ischemia Model through PPAR/HGF/cMet/eNOS Pathway (Oral)
    Kanbara Y, Sanada F, Taniyama Y, Iwabayashi M, Ikeda-Iwabu Y, Azuma J, Rakugi H, Morishita R
  • The 18th International Vascular Biology Meeting（IVBM 2014) (4.14, Kyoto, Japan)
    Expression and Role of Periostin in Ischmic Brain.
    Kurinami H, Shimamura M, Taniyama Y, Nakagami H, Katsuragi N, Wakayama K, Koriyama H, Tenma A, Tomioka H, Morishita R
  • The 18th International Vascular Biology Meeting（IVBM 2014) (4.14, Kyoto, Japan)
    Stem Cell Factor Activates Hypoxic Carduac Stem Cells reversing Myocardial Aging.
    Sanada F, Taniyama Y, Azuma J, Kanbara Y, Ikeda-Iwabu Y, Rakugi H, Morishita R
  • The 18th International Vascular Biology Meeting（IVBM 2014) (4.14, Kyoto, Japan)
    Hepatocyte Growth Factor attenuates Inflammation and Fas signaling via EGF Receptor Degradation under LPS Stimulation.
    Shimizu K, Taiyama Y, Sanada F, Azuma J, Kanbara Y, Ikeda-Iwabu Yuka, Morishita R
  • The 18th International Vascular Biology Meeting（IVBM 2014) (4.14, Kyoto, Japan)
    Cilostazol inproves Blood Flow in Hind Limb Ischemia Model through PPAR/HGF/cMet Axis.
    Kanbara Y, Sanada F, Taniyama Y, Iwabayashi M, Ikeda-Iwabu Y, Azuma J, Rakugi H
  • ＜2013年＞
  • The 86th American Heart Association, Scientific Session 2013 (11.20.Dallas)
    Nicotine Accelerates the Expansion of Abdominal Aortic Aneurysms via a Matricellular Protein, Periostin (Poster)
    Junya Azuma, Rei Otsu, Yoshiaki Taniyama, Masaaki Iwabayashi, Ryuichi Morishita
  • Basic Cardiovascular Sciences (BCVS) 2013 Scientific Sessions (7.21.Las Vegas)
    The impact of Periostin splicing isoforms in cardiac remodeling
    Junya Azuma, Yoshiaki Taniyama, Rei Otsu, Naruto Katsuragi, Keita Okayama, Kazuma Iekushi, Masaaki Iwabayashi, Ryuichi Morishita
  • ＜2012年＞
  • The 20th Annual Meeting of the Japanese Vascular Biology and Medicine Organization
    The 10th Korea-Japan Joint Symposium on Vascular Biology     (12.7.Tokushima)
    Symposium 6 / Hypertension
    Is hypertension related to the growth of abdominal aortic aneurysm?
    J Azuma, Y Taniyama, H Rakugi, R Morishita
  • The 20th Annual Meeting of the Japanese Vascular Biology and Medicine Organization
    The 10th Korea-Japan Joint Symposium on Vascular Biology     (12.7.Tokushima)
    Vascular inflammation2, Vascular endothelium / cell-cell communication2
    Chair parson; Yoshiaki Taniyama
  • The 85th American Heart Association, Scientific Session 2012 (11.4.Los Angeles)
    Periostin Regulates Aortic Rupture and Remodeling in Angiotensin II Induced Abdominal Aortic Aneurysm
    Junya Azuma, Yoshiaki Taniyama, Rei Otsu, Takashi Miyake, Kazuma Iekushi, Masaaki Iwabayashi, Ryuichi Morishita
  • The 85th American Heart Association, Scientific Session 2012 (11.6.Los Angeles)
    Protection From Obesity and Systemic Insulin Resistance by Hepatocyte Growth Factor in Mice
    Masaaki Iwabayashi, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Fumihiro Sanada, Amarnath Chatterjee, Hiromi Rakugi, Ryuichi Morishita
  • The 24th International Society of Hypertension (10.1.Sydney)
    Valsartan attenuates Lp(a)-induced severe neointimal hyperplasia: Possible contribution of integrin alphaV beta3 in vascular smooth muscle cell
    Masaaki Iwabayashi, Yoshiaki Taniyama, Junya Azuma, Fumihiro Sanada, Kazuma Iekushi, Keita Okayama, Hiroshi Kusunoki, Amarnath Chatterjee, Hiromi Rakugi, Ryuichi Morishita
  • The 24th International Society of Hypertension (10.2.Sydney)
    Cardiac and renal protective effects of hepatocyte growth factor (HGF), induced by Irbesartan in mouse model of salt-sensitive hypertension
    Hiroshi Kusunoki, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Rei Otsu, Masaaki Iwabayashi, Keita Okayama, Hiromi Rakugi, Ryuichi Morishita
  • The 24th International Society of Hypertension (10.3.Sydney)
    Evidence of contribution of perioxisome-proliferator activated receptor gamma activation to organ protective actions of telmisartan independent of angiotensin II type 1 receptor blockade
    Hiroshi Kusunoki, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Rei Otsu, Masaaki Iwabayashi, Keita Okayama, Hiromi Rakugi, Ryuichi Morishita
  • The 24th International Society of Hypertension (10.3.Sydney)
    Role of serotonin in angiogenesis: Induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice
    Masaaki Iwabayashi, Yoshiaki Taniyama, Junya Azuma, Fumihiro Sanada, Kazuma Iekushi, Keita Okayama, Hiroshi Kusunoki, Amarnath Chatterjee, Hiromi Rakugi, Ryuichi Morishita
  • The International Vascular Biology Symposium in Nagoya 2012 (8.8.Nagoya)
    Which is better to inhibit, or administrate periostin for patients with ischemic diseases?
    Taniyama Y
  • ＜2011年＞
  • The 84th American Heart Association, Scientific Session 2011 (11.14.Orlando)
    Role of Serotonin in Angiogenesis: Induction of Angiogenesis by Sarpogrelate via Endothelial 5-HT1B/Akt/eNOS Pathway in Diabetic Mice (poster)
    Masaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, Junya Azuma, Kazuma Iekushi, Hiroshi Kusunoki, Amarnath Chatterjee, Keita Okayama, Hiromi Rakugi, Ryuichi Morishita
  • The 84th American Heart Association, Scientific Session 2011 (11.15.Orlando)
    Selective Blockade of Periostin Isoform Decreased Infarct Size and Preserved Cardiac Performance in Acute Myocardial Infarction (oral)
    Keita Okayama, Yoshiaki Taniyama, Naruto Katsuragi, Junya Azuma, Kazuma Iekushi, Nobutaka Koibuchi,Hiroshi Kusunoki, Masaaki Iwabayashi, Hiromi Rakugi, and Ryuichi Morishita
  • The 84th American Heart Association, Scientific Session 2011 (11.16.Orlando)
    Hepatocyte growth factor attenuate lipoprotein(a) induced atherosclerotic pathway (poster)
    Masaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, Junya Azuma, Kazuma Iekushi, Hiroshi Kusunoki, Amarnath Chatterjee, Keita Okayama, Hiromi Rakugi, Ryuichi Morishita
  • The 59th American College of Cardiology (4.2.New Orleans)
    Prevention of End MT and Myofibloblast Proliferation As a Therapeutic Target For Cardiac Fibrosis; Okayama K, Taniyama Y, Dosaka N, Azuma J, Sanada F, Kusunoki H, Iwabayashi M, Rakugi H, Morishita R
  • International Stroke Conference 2011 (2.9.Los Angeles, CA)
    Role Of Periostin In Cerebral Ischemia
    Shimamura M, Taniyama Y, Nakagami H, Sato N, Koibuchi N, Allahtavakoli M, Wakayama K, Miyake T, Shimizu H, Morishita R
  • ＜2010年＞
  • The 8th Korea-Japan Symposium on Vascular Biology (12.1.Osaka)
    New concept of therapeutic strategy for ischemic disease
    Cirostazol protects vascular inflammatory and senescence through HGF up-regulation
    Taniyama Y
  • 83rd American Heart Association, Scientific Session 2010 (11.17.Chicago)
    Protective effects of hepatocyte growth factor on LPS induced inflammation via epithelial growth factor receptor degradation.
    Iwabayashi M, Taniyama Y, Shimizu K, Sanada F, Kyutoku M, Azuma J, Iekushi K, Okayama K, Kusunoki H, Morishita R.
  • The 23rd International Society of Hypertension (10.2.Vancouver)
    Hepatocyte Growth Factor Reduces Cardiac Fibrosis through Inhibiting Endothelial-Mesenchymal Transition and Proliferation of Myofibroblast
    Okayama K, Taniyama Y, Dosaka N, Iekushi K, Azuma J, Iwabayashi M, Kusunoki H, Kyutoku M, Amarnath C, Rakugi H, and Morishita R
  • The 23rd International Society of Hypertension (9.30.Vancouver)
    Hepatocyte growth factor attenuates TGF-b- angiotensin II crosstalk by down regulation of angiotensin II type 1 receptor through PTEN/Akt pathway.
    Kusunoki H, Taniyama Y, Iekushi K, Azuma J, Okayama K, Iwabayashi M, Kyutoku M, Amarnath C, Rakugi H, and Morishita R
  • XXth World Congress of the International Society for Heart Research (5.16.Kyoto)
    Cellular metabolism and energetics
    Chair person; Taniyama Y
  • XXth World Congress of the International Society for Heart Research (5.13.Kyoto)
    Hepatocyte growth factor (HGF) and prostacyclin synthase (PGIS); a dynamic duo for therapeutic angiogenesis
    Taniyama Y, Rakugi H, Morishita R
  • XXth World Congress of the International Society for Heart Research (5.13.Kyoto)
    Angiotensin II blockade decrease cardiac fibrosis and remodeling through hepatocyte growth factor.
    Taniyama Y, Rakugi H, Morishita R
  • Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference 2010 (4.13.Sanfrancisco)
    Protective effects of hepatocyte growth factor on LPS induced inflammation via epithelial growth factor receptor degradation.
    Taniyama Y, Shimizu K, Sanada F, Kyutoku M, Azuma J, Iekushi K, Okayama K, Kusunoki H, Iwabayashi M, Rakugi H, Morishita R.
  • ＜2009年＞
  • 14th International Symposium on Atherosclerosis (12.13.Boston)
    Ursodeoxycholic acid inhibits endothelial cell plasminonen activator inhibitor-1 expression induced by high glucose
    Hideki Yokoi, Yoshiaki Taniyama, Kazuma Iekushi, Fumihiro Sanada, Ryuichi Morishita
  • 82nd American Heart Association, Scientific Session 2009 (11.16.Orlando)
    Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-β1 Suppression by Anoikis of Myofibroblasts
    Iekushi Kazuma, Yoshiaki Taniyama, Junya Azuma, Fumihiro Sanada, Norio Dosaka, Hiroshi Kusunoki, Nobutaka Koibuchi, Keita Okayama, Hiromi Rakugi and Ryuichi Morishita
  • ＜2008年＞
  • 48th The American Society for Cell Biology Annual Meeting (12.13.San Francisco)
    HIF-1a-dependent expression of Nkx2.5 is required on normal heart development in Xenopus
    Kaori Nagao, Yoshiaki Taniyama, Naoki Mochizuki, Ryuichi Morishita
  • 81st American Heart Association, Scientific Session 2008 (11.9.Orlando)
    Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-β1 Suppression by Anoikis of Myofibroblasts
    Iekushi Kazuma, Yoshiaki Taniyama, Junya Azuma, Fumihiro Sanada, Norio Dosaka, Hiroshi Kusunoki, Nobutaka Koibuchi, Hiromi Rakugi and Ryuichi Morishita
  • 41st Annual Meeting of the American Society of Nephrology (11.6.Philadelphia)
    Hepatocyte Growth Factor attenuates TGF-[beta]- Angiotensin II Crosstalk by Down
    Regulation of Angiotensin II Type 1 Receptor through PTEN/Akt Pathway
    Iekushi Kazuma, Yoshiaki Taniyama, Junya Azuma, Fumihiro Sanada, Norio Dosaka, Nobutaka Koibuchi, Hiromi Rakugi and Ryuichi Morishita
  • 22nd International Society of Hypertension (6.17.Berlin)
    Hepatocyte growth factor, but not vascular endothelial growth factor, attenuated Ang II-induced senescence in EPC through anti-oxidative stress effect by inhibiting Rac1 activation. (Oral presentation)
    Fumihiro Sanada, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Norio Dosaka, Toyohiko Yokoi, Yoshifusa Aizawa, Ryuichi Morishita
  • 22nd International Society of Hypertension (6.17.Berlin)
    Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-β1 Suppression by Anoikis of Myofibroblasts
    Iekushi Kazuma, Yoshiaki Taniyama, Junya Azuma, Fumihiro Sanada, Norio Dosaka, Hiroshi Kusunoki, Hiromi Rakugi and Ryuichi Morishita
  • 22nd International Society of Hypertension (6.17.Berlin)
    HGF Reduces Myocardial Fibrosis via the Inhibition of TGF-b in Chronic Pressure Overload Mice Heart.
    Norio Dosaka, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Fumihiro Sanada, Hiromi Rakugi, Ryuichi Morishita
  • 15th International Vascular Biology Meeting (6.1.Sydony)
    HGF Reduces Myocardial Fibrosis in Chronic Pressure Overload Mice Heart.
    Norio Dosaka, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Fumihiro Sanada, Hiromi Rakugi, Ryuichi Morishita
  • ＜2007年＞
  • 80th American Heart Association, Scientific Session 2007 (11.6.Orlando)
    Hepatocyte growth factor, but not vascular endothelial growth factor, attenuated Ang II-induced senescence in EPC through anti-oxidative stress effect by inhibiting Rac1 activation. (Oral presentation)
    Fumihiro Sanada, Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Norio Dosaka, Toyohiko Yokoi, Yoshifusa Aizawa, Ryuichi Morishita
  • 17th European Society of Hypertension (6.12.Madrid)
    New mechanisms of valsartan, on the treatment of AMI through the inhibition of novel anti-adhesion molecule, periostin
    Kazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, Toshio Ogihara, Ryuichi Morishita
  • ＜2006年＞
  • 79th American Heart Association, Scientific Session 2006 (11.15.Chicago)
    HIF1 contribute to heart development in Xenopus
    Kaori Nagao, Yoshiaki Taniyama, Toshio Ogihara, Ryuichi Morishita
  • 12th International Symposium on SHR (10.20.Kyoto)
    Multiple functions of hepatocyte growth factor on cardiovascular disease
    Yoshiaki Taniyama
  • 21st Scientific Meeting of International Society of Hypertension (10.18.Fukuoka)
    Improvement of myocardial dysfunction by therapeutic angiogenesis and anti-fibrotic effects by HGF transfer in porcine chronic myocardial ischemia model
    Junya Azuma, Yoshiaki Taniyama, Kazuma Iekushi, Toshio Ogihara, Ryuichi Morishita
  • 21st Scientific Meeting of International Society of Hypertension (10.18.Fukuoka)
    HIF1 contribute to heart development in Xenopus
    Kaori Nagao, Yoshiaki Taniyama, Toshio Ogihara, Ryuichi Morishita
  • 21st Scientific Meeting of International Society of Hypertension (10.18.Fukuoka)
    VEGF isoforms differently contribute to development of blood vessels and blood cells in Xenopus
    Yoshiaki Taniyama, Junya Azuma, Kazuma Iekushi, Toshio Ogihara, Ryuichi Morishita
  • 21st Scientific Meeting of International Society of Hypertension (10.18.Fukuoka)
    New mechanisms of valsartan, on the treatment of AMI through the inhibition of novel anti-adhesion molecule, periostin
    Kazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, Toshio Ogihara, Ryuichi Morishita
  • 16th European Society of Hypertension (6.12.Madrid)
    New mechanisms of an angiotensin receptor blocker, valsartan, on the heart failure through the inhibition of novel anti-adhesion molecule, periostin
    Kazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, Toshio Ogihara, Ryuichi Morishita
  • ＜2005年＞
  • 78th American Heart Association, Scientific Session 2005 (Dallas, Texas)
    VEGF Isoforms Differently Contribute to Development of Blood Vessels and Blood Cells in Xenopus
    Kaori Nagao, Yoshiaki Taniyama, Toshio Ogihara, Ryuichi Morishita
  • ＜2004年＞
  • 19th International Society of Hypertension (Sao Paulo Brazil)
    Anti-apoptic effects of hepatocyte growth factor improve heart function and mortality against doxorubicin-induced heart failure
    Yoshiaki Taniyama, Junya Azuma, Toshio Ogihara, Ryuichi Morishita
  • 19th International Society of Hypertension (Sao Paulo Brazil)
    Enhanced therapeutic angiogenesis by co-transfection of prostacyclin synthase gene
    Yoshiaki Taniyama, Kazuya Hiraoka, Toshio Ogihara, Ryuichi Morishita
  • 4th International Society of Therapeutic Ultrasound (9.18.Kyoto)
    Modification of Pkasmid DNA-based Gene Transfer with Microbubulles
    Yoshiaki Taniyama
  • 7th Asian Federation of Society of Ultrasound in Medicine and Biology (AFSUMB) (5.21.Utsunomiya)
    Modification of pkasmid DNA-based gene transfer into central nerve system　Yoshiaki Taniyama
  • 77th American Heart Association, Scientific Session 2004 (New Orleans)
    VEGF isoforms differently contribute to development of blood vessels and blood cells in Xenopus
    Nobutaka Koibuchi, Yoshiaki Taniyama, Toshio Ogihara, Ryuichi Morishita
  • 77th American Heart Association, Scientific Session 2004 (New Orleans)
    Periostin as a novel factor responsible for ventricular dilation.
    Naruto Katsuragi, Yoshiaki Taniyama, Toshio Ogihara, Ryuichi Morishita
  • ＜2003年＞
  • 76th American Heart Association, Scientific Session 2003 (Orlando)
    VEGF(164) induces transformation blood cells precursors into endothelial cells in developing blood island.
    Nobutaka Koibuchi, Yoshiaki Taniyama, Toshio Ogihara, Ryuichi Morishita
  • ＜2002年＞
  • 75th American Heart Association, Scientific Session 2002 (Chicago)
    Cardiac-specific expression of Akt3 improves heart function and protects against doxorubicin-induced heart failure in young mice but not in old mice.
    Yoshiaki Taniyama, Kenneth Walsh
  • ＜2001年＞
  • 74th American Heart Association, Scientific Session 2001 (Anaheim)
    Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth
    Yoshiaki Taniyama, Kenneth Walsh
  • ＜2000年＞
  • 3rd American Society of Gene Therapy (Denver)
    Therapeutic angiogenesis using hepatocyte growth factor (HGF) in rat hindlimb ischemia model
    Yoshiaki Taniyama, Ryuichi Morishita, Naruya Tomita, Motokuni Aoki, Yasufumi Kaneda, Toshio Ogihara
  • 18th International Society of Hypertension (Chicago)
    Pre-clinical study of therapeutic angiogenesis using hepatocyte growth factor (HGF) in rat and rabbit hindlimb ischemia model
    Yoshiaki Taniyama, Ryuichi Morishita, Motokuni Aoki, Toshio Ogihara
  • 53rd Council for High Blood Pressure Research (Washington)
    Pre-clinical study of therapeutic angiogenesis using hepatocyte growth factor (HGF) in rat and rabbit hindlimb ischemia model; comparison of angiogenic activity of rHGF and HGF plasmid
    Yoshiaki Taniyama, Ryuichi Morishita, Motokuni Aoki, Kei Yamamoto, Keita Yamasaki, Yasufumi Kaneda, Toshio Ogihara
  • 73rd American Heart Association, Scientific Session 2000 (New Orleans)
    Local Delivery of Naked Plasmid DNA of P53 Gene into Rat Balloon Injured Carotid Artery Using Low Voltage Ultrasound with Contrast Microbubbles (Optison): Development of Novel Non-Viral Transfection System into Blood Vessels
    Yoshiaki Taniyama, Katsuro Tachibana, Kei Yamamoto
  • ＜1999年＞
  • International Society for Heart Research (Tokyo)
    Prevention of Myocardial Injury and Fibrosis by Angiotensin II Blockade in Cardiomyopathic Hamster: Role of Hepatocyte Growth Factor
    Taniyama Y., Morishita R., Matsushita H., Tomita N., Higaki J., Ogihara T.
  • 52nd Council for High Blood Pressure Research (Orlando)
    Prevention of myocardial injury and fibrosis by angiotensin II blockade in cardiomyopathic hamster: Potential contribution of hepatocyte growth factor.
    Yoshiaki Taniyama, Ryuichi Morishita, Hidetsugu Matsushita, Jitsuo Higaki, Toshio Ogihara.
  • 72nd American Heart Association, Scientific Session 1999 (Atlanta)
    Pre-clinical study of therapeutic angiogenesis using hepatocyte growth factor (HGF) in rat hindlimb ischemia model; comparison of angiogenic activity of rHGF, HGF plasmid alone and HGF gene transfer using HVJ-liposome method.
    Yoshiaki Taniyama, Ryuichi Morishita, Motokuni Aoki, Toshio Ogihara. Circulation Supple-I. 1999 Dec; vol. 100, no. 18, I-136
  • 72nd American Heart Association, Scientific Session 1999 (Atlanta)
    Cardio-protective effects of hepatocyte growth factor (HGF) gene transfer into myocardium of cardiomyopathic hamster (Bio 14.6): novel gene therapy strategy for cardiomyopathy.
    Yoshiaki Taniyama, Motokuni Aoki, Toshie Nata, Hironori Nakagami, Ryuichi Morishita. Circulation. Supple-I. 1999 Dec; vol. 100, no. 18, I-47
  • 72nd American Heart Association, Scientific Session 1999 (Atlanta)
    Transcription factor ets-1 is a key regulator in actions of anti-fibrosis and pro-angiogenesis of hepatocyte growth factor (HGF) in human fibroblasts and vascular smooth muscle cells.
    Yoshiaki Taniyama, Kei Yamamoto, Naruya Tomita. Circulation. Supple-I. 1999 Dec; vol. 100, no. 18, I-336
  • ＜1998年＞
  • 10th International Vascular Biology Meeting (Australia)
    Prevention of myocardial injury and fibrosis by angiotensin II blockade in cardiomyopathic hamster
    Yoshiaki Taniyama, Ryuichi Morishita, Hidetsugu Matsushita, Jitsuo Higaki, Toshio Ogihara
  • 17th International Society of Hypertension (Amsterdam)
    Potential contribution of hepatocyte growth factor: Prevention of myocardial injury and fibrosis by angiotensin II blockade in cardiomyopathic hamster:.
    Yoshiaki Taniyama, Ryuichi Morishita, Hidetsugu Matsushita, Jitsuo Higaki, Toshio Ogihara
  • 71st American Heart Association, Scientific Session 1998 (Dallas)
    Anti-fibrotic action of hepatocyte growth factor by up-regulation of matrix metalloprotease-1 and urokinase-type plasminogen activator (uPA) in human fibroblasts and vascular smooth muscle cells.
    Yoshiaki Taniyama, Keiko Matsumoto, Hironori Nakagami. Circulation. Supple-I. 1998 Dec; vol. 100, no. 18, I-136
  • 71st American Heart Association, Scientific Session 1998 (Dallas)
    Prevention of myocardial injury and fibrosis by angiotensin II blockade in cardiomyopathic hamster: Role of hepatocyte growth factor.
    Yoshiaki Taniyama, Ryuichi Morishita, Hidetsugu Matsushita, Naruya Tomita, Jitsuo Higaki, Toshio Ogihara. Circulation. Supple-I. 1998 Dec; vol. 100, no. 18, I-136
  • ＜1997年＞
  • 45th American College of Cardiology (Anaheim)
    Intravenous nicorandil can preserve microvascular integrity and prevent complications in patients with acute myocardial infarction. JACC. Supple. 1997 January
    Yoshiaki Taniyama, Hiroshi Ito, Katsuomi Iwakura, Nagahiro Nishikawa, Kenshi Fujii.
  • 70th American Heart Association, Scientific Session 1997 (Orlando)
    Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with acute myocardial infarction.
    Yoshiaki Taniyama, Hiroshi Ito, Katsuomi Iwakura, Kenshi Fujii. Circulation. Supple-I. 1997 Oct; vol. 94, no. 8, I-456
  • ＜1996年＞
  • 69th American Heart Association, Scientific Session 1996 (New Orleans)
    Early identification of stunned myocardium in patients with acute right ventricular myocardial infarction.
    Yoshiaki Taniyama, Hiroshi Ito, Katsuomi Iwakura, Nagahiro Nishikawa, Shin Takiuchi. Circulation. Supple-I. 1996 Oct; vol. 94, no. 8, I-456
  • ＜1995年＞
  • 68th American Heart Association, Scientific Session 1995 (Anaheim)
    Coronary flow velocity pattern in patients with TIMI flow grade 2; its relation to residual coronary stenosis and microvascular dysfunction.
    Yoshiaki Taniyama, Katsuomi Iwakura, Hiroshi Ito, Shin Takiuchi, Atsunori Okamura, Atsushi Maruyama, Hisakazu Fuji, Shinji Negoro, Yoshiaki Nakatsuchi, Yorihiko Higashino, Kenshi Fujii. Circulation. Supple-I. 1995 Oct; vol. 92, no. 8, I-149
  • 68th American Heart Association, Scientific Session 1995 (Anaheim)
    Effects of intracoronary injection of verapamil and nicorandil on microvasculation and left ventricular function in patients with reperfused myocardial infarction.
    Yoshiaki Taniyama, Hiroshi Ito, Katsuomi Iwakura, Shin Takiuchi, Atushi Maruyama, Kenshi Fujii. Circulation. Supple-I. 1995 Oct; vol. 92, no. 8, I-77
  • ＜1994年＞
  • World Doppler Congress (Sapporo)
    Coronary flow velocity pattern in patients with TIMI flow grade 2
    Yoshiaki Taniyama, Katsuomi Iwakura, Hiroshi Ito, Shin Takiuchi, Atsunori Okamura, Atsushi Maruyama, Hisakazu Fuji, Shinji Negoro, Yoshiaki Nakatsuchi, Yorihiko Higashino, Kenshi Fujii.
News 臨床研究 英字論文 英字著書 和文著書 日本語総説・解説 国際学会 国内学会
  Gリーダー 研究テーマ 所属メンバー 主な論文
[心・血管グループ]
Page Top